STOCK TITAN

Insight affiliates trim Hinge Health (HNGE) stake with 142,311-share sale

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Hinge Health, Inc. disclosed that investment entities associated with Insight Venture Partners reported open-market sales of Class A Common Stock. On June 24, 2026, these entities sold a combined 142,311 shares at a reported price of $71.6669 per share through indirect ownership accounts. The Form 4 indicates these particular indirect positions now report zero shares following the transactions, and there are no remaining derivative securities listed in this filing.

Positive

  • None.

Negative

  • None.
Insider Insight Holdings Group, LLC, Insight Venture Associates X, Ltd., Insight Venture Associates X, L.P., Insight Venture Partners X, L.P., Insight Venture Partners (Cayman) X, L.P., Insight Venture Partners (Delaware) X, L.P., Insight Venture Partners X (Co-Investors), L.P.
Role null | null | null | null | null | null | null
Sold 142,311 shs ($10.20M)
Type Security Shares Price Value
Sale Class A Common Stock 119,244 $71.6669 $8.55M
Sale Class A Common Stock 23,067 $71.6669 $1.65M
Holdings After Transaction: Class A Common Stock — 0 shares (Indirect, See Footnotes)
Footnotes (1)
  1. See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1
Total shares sold 142,311 shares Open-market sales of Class A Common Stock on June 24, 2026
Sale price per share $71.6669 per share Reported for both open-market transactions
First transaction size 23,067 shares Class A Common Stock sold indirectly on June 24, 2026
Second transaction size 119,244 shares Class A Common Stock sold indirectly on June 24, 2026
Shares after first sale 0.0000 shares Total shares following first reported transaction
Shares after second sale 0.0000 shares Total shares following second reported transaction
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
indirect ownership financial
"direct_or_indirect: I, ownership_type: indirect"
ten percent owner financial
"is_ten_percent_owner: 1 for multiple reporting persons"
Class A Common Stock financial
"security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Insight Holdings Group, LLC

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/22/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/24/2026S(6)119,244D$71.6669(5)0ISee Footnotes(1)(3)(4)
Class A Common Stock06/24/2026S(6)23,067D$71.6669(5)0ISee Footnotes(2)(3)(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
Insight Holdings Group, LLC

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Insight Venture Associates X, Ltd.

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Insight Venture Associates X, L.P.

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Insight Venture Partners X, L.P.

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Insight Venture Partners (Cayman) X, L.P.

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Insight Venture Partners (Delaware) X, L.P.

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Insight Venture Partners X (Co-Investors), L.P.

(Last)(First)(Middle)
C/O INSIGHT PARTNERS
1114 AVENUE OF THE AMERICAS, 36TH FLOOR

(Street)
NEW YORK NEW YORK 10036

(City)(State)(Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. See Exhibit 99.1
2. See Exhibit 99.1
3. See Exhibit 99.1
4. See Exhibit 99.1
5. See Exhibit 99.1
6. See Exhibit 99.1
Remarks:
Exhibit List Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filers' Signatures
Insight Holdings Group, LLC, by Andrew Prodromos, its Authorized Signatory /s/ Andrew Prodromos06/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Hinge Health (HNGE) report in this Form 4?

Hinge Health reported insider sales of Class A Common Stock. Investment entities associated with Insight Venture Partners disclosed open-market sales totaling 142,311 shares of Hinge Health Class A Common Stock, as reflected in a Form 4 filed with the SEC.

How many HNGE shares were sold by the Insight-affiliated entities?

The filing shows total sales of 142,311 HNGE shares. The transactions consisted of 23,067 shares in one trade and 119,244 shares in another, all involving Class A Common Stock held indirectly by Insight-affiliated entities.

At what price were Hinge Health (HNGE) shares sold in the reported trades?

The reported sale price was $71.6669 per HNGE share. Both disclosed open-market transactions in Class A Common Stock used this same price per share in the Form 4 details for June 24, 2026.

When did the Insight-affiliated entities sell HNGE Class A Common Stock?

The reported sales occurred on June 24, 2026. On that date, Insight-affiliated investment entities executed two open-market transactions in Hinge Health Class A Common Stock, as recorded in the Form 4 filing.

Were the HNGE share sales direct or indirect holdings of the reporting persons?

The HNGE shares sold were reported as indirect holdings. Each transaction is marked with indirect ownership and references footnotes directing readers to Exhibit 99.1 for further details about the ownership structure.

Do the Insight-affiliated entities report remaining HNGE shares after these transactions?

The Form 4 shows zero shares following each reported transaction. For both open-market sales of Hinge Health Class A Common Stock, the line items list total shares following the transactions as 0.0000 for the reported indirect positions.